UAB Med Cast
UAB Med Cast
Cystic Fibrosis: New CF Research & Clinical Trials
Loading
/
  • LISTEN ON:
  • Listen on Spotify
  • Listen on iHeart
  • Listen on Apple Podcasts
  • Listen on Google Podcasts
  • Listen on TuneIn
  • Listen on Stitcher
  • Subscribe via RSS
Placeholder Ad
Placeholder Ad
Placeholder Ad
Placeholder Ad

Cystic Fibrosis: New CF Research & Clinical Trials

Show: (May 16, 2022)

cystic-fibrosis-new-cf-research-clinical-trialsAlthough most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, around 15% of patients are still without a treatment option. George Solomon, MD, discusses how UAB’s participation in the international “Path to a Cure” initiative will expand treatment options for all CF patients. He summarizes the three prongs of the path: developing a wider range of protein modulators, finding safe and ethical ways to administer genetic therapies, and ultimately finding a universal cure for CF. But what can we do now for CF patients with less common mutations? Learn more about how the UAB Medicine Cystic Fibrosis Program gives patients with tough-to-treat protein mutations access to emerging therapies through clinical trials.

Top Three Options for Breast Reconstruction

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Multidisciplinary Consensus in Diagnosis and Treatment Options of Spontaneous Intracranial Hypotension

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Innovative Robotic Coronary Artery Bypass (CABG) Surgery Offers Patients Faster Recovery

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Left Atrial Appendage Occlusion Devices and Procedures

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Multi-Disciplinary Hepatocellular Carcinoma Clinic (HCC)

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

The Intricate Nature of Head and Neck Cancer Surgery

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Degenerative Mitral Valve Disease

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Undiagnosed Diseases Program: Finding Answers in Mysterious Conditions

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Mechanical Thrombectomy for Stroke

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen

Using Telehealth to Improve Access to Trauma Care Among Injured Rural Patients in the US

Although most cystic fibrosis (CF) patients respond to new drug combinations which activate the proteins commonly affected by the disease, ...

Listen